Westport Fuel Systems Reports Third Quarter 2020 Financial Results

VANCOUVER, British Columbia, Nov. 09, 2020 (GLOBE NEWSWIRE) — Westport Fuel Systems Inc. (“Westport Fuel Systems” or “the Company“) (TSX:WPRT / Nasdaq:WPRT) reported financial results for the third quarter ended September 30, 2020 and provided an update on operations. All figures are in millions of U.S. dollars unless otherwise stated. Key […] Lire la suite »

Novavax Reports Third Quarter 2020 Financial and Operational Results

Advanced clinical development of NVX‑CoV2373 with initiation of first Phase 3 trial to evaluate efficacy, safety and immunogenicity U.K. Phase 3 interim data expected as soon as early first quarter 2021 Secured additional large-scale manufacturing for NVX-CoV2373 with expected global capacity over two billion doses by mid-2021 Formed leadership team […] Lire la suite »

Inventiva annonce sa participation à la « Stifel Virtual Healthcare Conference 2020 » et la « 11th Jefferies Virtual Healthcare Conference »

Daix (France), le 9 novembre 2020 – Inventiva (Euronext Paris et Nasdaq : IVA), société biopharmaceutique spécialisée dans le développement clinique de petites molécules administrées par voie orale pour le traitement de la stéatohépatite non alcoolique (NASH), des mucopolysaccharidoses (MPS) et d’autres maladies avec un besoin médical non satisfait significatif, […] Lire la suite »

Inventiva to participate at the Stifel Virtual Healthcare Conference 2020 and the 11th Jefferies Virtual Healthcare Conference

Daix (France), November 9, 2020 – Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS) and other diseases with significant unmet medical need, today announced its participation at the Stifel Virtual […] Lire la suite »

ERYTECH gibt ein Unternehmens-Update und vermeldet die Geschäftsergebnisse für das dritte Quartal 2020

Phase-III-Studie TRYbeCA-1 zur Zweitlinienbehandlung bei metastasierendem Pankreaskrebs: Mehr als 95 % der ca. 500 Patienten wurden bereits aufgenommen Anzahl der erforderlichen Ereignisse für die Interims-Überlegenheitsanalyse wurde erreicht Interims-Überlegenheitsanalyse wird voraussichtlich im ersten Quartal 2021 durchgeführt Von der NOPHO gesponserte Phase-II-Studie zur Behandlung von akuter lymphoblastischer Leukämie: Rekrutierung der Patienten ist abgeschlossen: Aufnahme […] Lire la suite »

Brunswick Exploration Announces Management Changes

MONTREAL, Nov. 09, 2020 (GLOBE NEWSWIRE) — Brunswick Exploration Inc. (“BRW” or the “Company”) is pleased to announce that the Board of Directors has appointed Robert Wares, currently Chairman, as Chief Executive Officer of the Company, and Killian Charles as President of the Company. Mr. Charles currently works for Osisko […] Lire la suite »

Rackspace Technology Announces Cloud and Innovation Thought Leadership Strategy Series Virtual Roundtable with AWS and International Air Transport Association

SAN ANTONIO, Nov. 09, 2020 (GLOBE NEWSWIRE) — Rackspace Technology™ (NASDAQ: RXT), a leading end-to-end multicloud technology solutions company, will co-sponsor the Cloud — The Enabler of Innovation virtual event with Amazon Web Services (AWS) and International Air Transport Association on November 12 at 10:00 am CT. This webinar is […] Lire la suite »

Merus annonce ses résultats financiers pour le troisième trimestre et fait le point sur ses activités

–Mise à jour des données cliniques du programme principal sur le Zenocutuzumab (« Zeno ») prévue pour le 2e trimestre 2021––Arrivée du programme MCLA-129 au stade clinique attendue courant 2021– UTRECHT, Pays-Bas et CAMBRIDGE, Mass., 09 nov. 2020 (GLOBE NEWSWIRE) — Merus N.V. (Nasdaq : MRUS) (la « Société », « nous » ou « notre/nos »), une société d’oncologie […] Lire la suite »

Merus gibt Finanzergebnisse für das dritte Quartal bekannt und legt ein Update zur Geschäftsentwicklung vor

–Update der klinischen Daten und des Programms für den führenden Produktkandidaten Zenocutuzumab („Zeno“) im zweiten Quartal 2021–– Erstmaliger Einsatz von MCLA-129 in der klinischen Praxis voraussichtlich 2021 – UTRECHT, Niederlande, und CAMBRIDGE, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) — Merus N.V. (Nasdaq: MRUS) („Merus“, „die Gesellschaft“, „wir“ oder „unser“), ein Unternehmen aus […] Lire la suite »

HPTN 084 Study Demonstrates Superiority of CAB LA to Oral FTC/TDF for the Prevention of HIV

Durham, N.C., Nov. 09, 2020 (GLOBE NEWSWIRE) — Researchers from the HIV Prevention Trials Network (HPTN) announced today data from the HPTN 084 clinical trial indicate that a pre-exposure prophylaxis (PrEP) regimen of long-acting cabotegravir (CAB LA) injections once every eight weeks was safe and superior to daily oral tenofovir/emtricitabine (FTC/TDF) for HIV prevention among cisgender women in sub-Saharan Africa. During a planned review of study data, an independent Data and Safety Monitoring Board (DSMB) recommended the study sponsor―the National […] Lire la suite »

Deloitte and AlgoSec Partner to Establish a Joint Network Protection Transformation Solution for Enterprises

RIDGEFIELD PARK, N.J., Nov. 09, 2020 (GLOBE NEWSWIRE) — The EMEA Telecom Engineering Centre of Excellence (TEE) of Deloitte (located in Portugal) and AlgoSec, the leading provider of business-driven network security management solutions, have entered into an alliance to establish a network protection transformation offer to safeguard clients against complex threats […] Lire la suite »

Novavax COVID-19 Vaccine Granted Fast Track Designation by U.S. FDA

GAITHERSBURG, Md., Nov. 09, 2020 (GLOBE NEWSWIRE) — Novavax, Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for NVX-CoV2373, the Company’s COVID-19 vaccine candidate. Currently in late-phase clinical development, NVXCoV2373 […] Lire la suite »

Constellation Brands and E. & J. Gallo Sign Agreement With Federal Trade Commission Staff Relating to Consent Order on Pending Transaction; Constellation Provides Business Update for Fiscal 2021

VICTOR, N.Y., Nov. 09, 2020 (GLOBE NEWSWIRE) — Constellation Brands, Inc. (NYSE: STZ and STZ.B), a leading beverage alcohol company, announced today that it and E. & J. Gallo Winery have signed an Agreement Containing Consent Order with the Bureau of Competition of the U.S. Federal Trade Commission (FTC) regarding […] Lire la suite »

Merus Announces Poster Presentations on MCLA-145 at Society for Immunotherapy of Cancer

UTRECHT, The Netherlands and CAMBRIDGE, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) — Merus N.V. (Nasdaq: MRUS) (“Merus”, “the Company”, “we”, or “our”), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics™), today announced that preclinical data from its MCLA-145 program will be presented at the Society for […] Lire la suite »

Algernon Pharmaceuticals Announces Plans to Provide Interim Data from its Ifenprodil Phase 2b/3 COVID-19 Human Study

VANCOUVER, British Columbia, Nov. 09, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical development company, is pleased to announce that it plans to conduct an interim data review of its multi-national Ifenprodil Phase 2b/3 COVID-19 human study. The […] Lire la suite »

Evelo Biosciences Presents New Preclinical Data for Anti-Tumor Effects of Orally Delivered Microbial Extracellular Vesicles at the SITC 35th Anniversary Annual Meeting

— EDP1908 demonstrates potent anti-tumor effects in murine models of cancer — — Oral extracellular vesicles have potential to be a completely novel mechanism of I/O therapy — CAMBRIDGE, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) — Evelo Biosciences, Inc. (Nasdaq:EVLO) a clinical stage biotechnology company developing a new modality of […] Lire la suite »

ZAGENO Doubles Engineering to Support High-Paced, Customer-Centric Operating Model Under Leadership of New VP of Engineering

CAMBRIDGE, Mass. and BERLIN, Germany and WROCLAW, Poland, Nov. 09, 2020 (GLOBE NEWSWIRE) — ZAGENO, a leading enterprise marketplace solution connecting eCommerce to life science, today announced that it is doubling the size of its engineering team to support its customer-centric operation model. ZAGENO’s newly appointed vice president of engineering Mathias […] Lire la suite »

Intellia Therapeutics Doses First Patient in Landmark CRISPR/Cas9 Clinical Trial of NTLA-2001 for the Treatment of Transthyretin Amyloidosis

NTLA-2001: First single-course therapy that potentially halts and reverses ATTR progression First-ever in vivo CRISPR treatment delivered intravenously to a patient CAMBRIDGE, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), announced that the first patient has been treated with NTLA-2001, which the company is developing as a […] Lire la suite »